Orchestra BioMed Holdings (OBIO) Accumulated Depreciation & Amortization (2022 - 2025)
Historic Accumulated Depreciation & Amortization for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $1.5 million.
- Orchestra BioMed Holdings' Accumulated Depreciation & Amortization rose 2698.93% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 2698.93%. This contributed to the annual value of $1.3 million for FY2024, which is 2480.84% up from last year.
- As of Q3 2025, Orchestra BioMed Holdings' Accumulated Depreciation & Amortization stood at $1.5 million, which was up 2698.93% from $1.5 million recorded in Q2 2025.
- Over the past 5 years, Orchestra BioMed Holdings' Accumulated Depreciation & Amortization peaked at $1.5 million during Q3 2025, and registered a low of $778000.0 during Q4 2022.
- Moreover, its 4-year median value for Accumulated Depreciation & Amortization was $1.1 million (2024), whereas its average is $1.1 million.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first soared by 3419.02% in 2023, then soared by 2275.93% in 2024.
- Orchestra BioMed Holdings' Accumulated Depreciation & Amortization (Quarter) stood at $778000.0 in 2022, then skyrocketed by 34.19% to $1.0 million in 2023, then grew by 24.81% to $1.3 million in 2024, then increased by 18.8% to $1.5 million in 2025.
- Its Accumulated Depreciation & Amortization stands at $1.5 million for Q3 2025, versus $1.5 million for Q2 2025 and $1.4 million for Q1 2025.